Heineken warns British pubs that weight-loss drugs could hurt beer sales

Reuters reports a Heineken presentation warned British pubs and bars that GLP-1 drugs could hurt beer and cider sales, advising them to promote half-pints, low- and no-alcohol drinks, and small plates. Heineken told Reuters that users are choosing smaller servings rather than abandoning alcohol altogether. In Circana data cited by Reuters, tracked US households with a GLP-1 user spent about 13.5% less on beer per month after two years on the drugs than households without a user.